Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 0 | 0 | 0 | 7,490 | 7,560 |
| Cost of Goods | N/A | N/A | N/A | 6,228 | 6,183 |
| Gross Profit | N/A | N/A | N/A | 1,261 | 1,377 |
| Operating Expenses | -2,194 | 5,728 | 7,406 | 12,563 | 61,269 |
| Operating Income | -5,295 | -5,728 | -7,406 | -11,073 | -59,709 |
| Interest Expense | 149 | 368 | 336 | 927 | 477 |
| Other Income | 4 | 5 | 9 | 6 | 13,325 |
| Pre-tax Income | -5,440 | -6,091 | -7,733 | -11,994 | -46,862 |
| Income Tax | N/A | N/A | N/A | 53 | -13,633 |
| Net Income Continuous | -5,386 | -6,091 | -7,733 | -12,048 | -33,228 |
| Net Income Discontinuous | -703 | -1,197 | -152 | N/A | N/A |
| Minority Interests | -131 | -405 | -50 | -67 | -31 |
| Net Income | $-5,958 | $-6,883 | $-7,835 | $-11,981 | $-33,197 |
| EPS Basic Total Ops | -7.20 | -16.34 | -19.94 | -31.33 | -85.01 |
| EPS Basic Continuous Ops | -5.85 | -14.24 | -19.49 | -31.48 | -85.04 |
| EPS Basic Discontinuous Ops | -1.35 | -1.95 | -0.45 | N/A | N/A |
| EPS Diluted Total Ops | -7.20 | -16.34 | -19.94 | -31.33 | -85.01 |
| EPS Diluted Continuous Ops | -5.85 | -14.24 | -19.49 | -31.48 | -85.04 |
| EPS Diluted Discontinuous Ops | -1.35 | -1.95 | -0.45 | N/A | N/A |
| EBITDA(a) | $2,293 | $-5,629 | $-7,891 | $-10,336 | $-6,025 |